Effect of Dysport Injections on Energy Expenditure and Walking Efficiency in Children With Cerebral Palsy
Status:
Completed
Trial end date:
2021-05-26
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the efficacy of single event multi level chemoneurolysis with the
abobotulinumtoxin A drug, Dysport®, on walking energy expenditure and gait in children with
spastic diplegia cerebral palsy.
Phase:
Phase 3
Details
Lead Sponsor:
Columbia University
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A onabotulinumtoxinA